Key Takeaways Mesenchymal stem cells (MSCs) have been tested in small rheumatoid arthritis (RA) trials, but no trial shows they stop the disease for good. A 2019 study of 64 people with RA reported lower disease scores at one and three years after umbilical cord cell infusion. A 2017 placebo-controlled
Key Takeaways Chronic, low-grade inflammation and insulin resistance drive each other in a two-way loop that starts largely in visceral fat. Mesenchymal stem cells are being studied for their ability to calm this inflammation and support insulin sensitivity, not to replace diet, exercise, or medication. A 2022 randomized trial found
Key Takeaways A 2026 study in Scientific Reports followed 49 patients with steroid-resistant GvHD treated with Wharton’s jelly MSCs at four hospitals in Spain. At day 28, 71.4% of patients responded to treatment. One-year survival reached 55.1%. Batches that scored above 70% on a potency test produced far better outcomes,
Quick Summary Mesenchymal stem cell (MSC) therapy for IBD (Crohn’s disease and ulcerative colitis) reduces inflammation, supports repair of damaged intestinal tissue, and helps balance immune response. It is not a replacement for biologics or steroids but may work alongside them. Clinical trials show improved gut symptoms and mucosal healing
Quick Read Summary Wondering about anti aging stem cell treatment vs traditional anti-ageing what actually changes inside your cells? This guide explains the cellular difference between regenerative therapy and conventional approaches. While traditional methods target surface-level signs like wrinkles and sagging skin, stem cell therapy works deeper by repairing damaged
